
Advanced Enzyme Technologies Ltd is Rated Sell
2026-09-30 10:10:30Advanced Enzyme Technologies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 August 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 30 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.
Read full news article
Advanced Enzyme Technologies Ltd Faces Bearish Momentum Amid Technical Downgrade
2026-09-25 08:04:46Advanced Enzyme Technologies Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in technical momentum, with key indicators signalling a bearish trend. The company’s current price stands at ₹292.70, down 1.46% from the previous close of ₹297.05, reflecting growing investor caution amid deteriorating technical signals and a downgrade in its Mojo Grade from Hold to Sell.
Read full news article
Advanced Enzyme Technologies Ltd: Technical Momentum Shifts Amid Mixed Market Signals
2026-09-23 08:04:18Advanced Enzyme Technologies Ltd has experienced a nuanced shift in its technical momentum, with key indicators signalling a transition from bearish to mildly bearish trends. Despite a modest day gain of 0.99%, the stock’s technical landscape reveals a complex interplay of bearish and mildly bullish signals across weekly and monthly timeframes, prompting a reassessment of its near-term outlook within the Pharmaceuticals & Biotechnology sector.
Read full news article
Advanced Enzyme Technologies Ltd is Rated Sell
2026-09-19 10:10:20Advanced Enzyme Technologies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 September 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article
Advanced Enzyme Technologies Ltd Faces Bearish Momentum Amid Technical Downgrade
2026-09-16 08:08:29Advanced Enzyme Technologies Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock, currently priced at ₹288.60, has seen a decline of 1.85% on the day, reflecting growing investor caution amid weakening technical signals and a downgrade in its mojo grade from Hold to Sell.
Read full news article
Advanced Enzyme Technologies Ltd Faces Mixed Technical Signals Amid Price Momentum Shift
2026-09-15 08:03:36Advanced Enzyme Technologies Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical parameters, reflecting a complex interplay of bearish and bullish signals. Despite a recent downgrade from Hold to Sell by MarketsMOJO, the stock’s price momentum and technical indicators reveal a nuanced picture that investors should carefully analyse.
Read full news article
Advanced Enzyme Technologies Ltd Faces Bearish Momentum Amid Technical Downgrade
2026-09-10 08:04:03Advanced Enzyme Technologies Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. Recent technical indicators, including MACD, RSI, and moving averages, signal increasing downside pressure, reflecting challenges in sustaining upward price momentum amid broader market volatility.
Read full news article
Advanced Enzyme Technologies Ltd is Rated Sell
2026-09-08 10:10:25Advanced Enzyme Technologies Ltd is rated Sell by MarketsMOJO, with this rating last updated on 25 August 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 08 September 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Advanced Enzyme Technologies Ltd: Technical Momentum Shifts Amid Mixed Market Signals
2026-09-08 08:07:24Advanced Enzyme Technologies Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, reflected in a downgrade of its Mojo Grade from Hold to Sell as of 25 Aug 2026. Despite a modest day gain of 1.33%, the stock’s technical indicators present a complex picture, with bearish trends dominating daily and weekly charts, while monthly signals offer mild bullish hints. This nuanced technical landscape warrants a detailed analysis for investors seeking clarity on the stock’s near-term trajectory.
Read full news articleAnnouncement under Regulation 30 (LODR)-Daily Buy Back of equity shares
28-Sep-2026 | Source : BSEDaily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on September 28 2026
Closure of Trading Window
28-Sep-2026 | Source : BSEPlease find enclosed herewith the intimation regarding the closure of the Trading Window with effect from October 01 2026.
Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
24-Sep-2026 | Source : BSEDaily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on September 24 2026
Corporate Actions
No Upcoming Board Meetings
Advanced Enzyme Technologies Ltd has declared 67% dividend, ex-date: 24 Jul 26
Advanced Enzyme Technologies Ltd has announced 2:10 stock split, ex-date: 25 May 17
No Bonus history available
No Rights history available






